OppenheimerFunds’s Agios Pharmaceuticals AGIO Stock Holding History

OppenheimerFunds’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$22.3M	Buy	330,652 +36,460	+12%	+$2.12M	0.03%	503
2018 Q4	$13.6M	Buy	294,192 +58,217	+25%	+$3.59M	0.02%	605
2018 Q3	$18.2M	Buy	235,975 +52,840	+29%	+$4.25M	0.02%	608
2018 Q2	$15.4M	Buy	183,135 +20,552	+13%	+$1.79M	0.02%	641
2018 Q1	$13.3M	Buy	162,583 +20,300	+14%	+$1.57M	0.02%	652
2017 Q4	$8.13M	Buy	142,283 +124,035	+680%	+$7.8M	0.01%	761
2017 Q3	$1.22M	Buy	+18,248	New	+$1.1M	﹤0.01%	1100

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OppenheimerFunds's AGIO Position: Q1 2019 in Review

OppenheimerFunds increased its Agios Pharmaceuticals (AGIO) stake by 12% in Q1 2019, buying an estimated $2.12M and bringing the position to 330,652 shares worth $22.3M. The position accounts for 0.03% of the portfolio, ranked #503.

OppenheimerFunds first reported a position in AGIO in Q3 2017 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

OppenheimerFunds held 330,652 shares of Agios Pharmaceuticals worth $22.3M as of Q1 2019.
OppenheimerFunds bought 36,460 Agios Pharmaceuticals shares in Q1 2019, an estimated $2.12M.
Agios Pharmaceuticals made up 0.03% of OppenheimerFunds's portfolio in Q1 2019, its #503 holding.
OppenheimerFunds first reported a position in Agios Pharmaceuticals in Q3 2017 and has held it in 7 quarters since.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.